Gene · 6385
Papers3,062
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,062
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma. | Gut | 2024 | 38839271 | PubTator, text mining | PubMed |
| Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol. | iScience | 2024 | 38832018 | PubTator, text mining | PubMed |
| Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality. | PLoS One | 2024 | 38739599 | PubTator, text mining | PubMed |
| Immune cell senescence and exhaustion promote the occurrence of liver metastasis in colorectal cancer by regulating epithelial-mesenchymal transition. | Aging (Albany NY) | 2024 | 38683136 | PubTator, text mining | PubMed |
| Syndecans, Exostosins and Sulfotransferases as Potential Synovial Inflammation Moderators in Patients with Hip Osteoarthritis. | Int J Mol Sci | 2024 | 38674142 | PubTator, text mining | PubMed |
| CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications. | Biochimie | 2024 | 38640996 | PubTator, text mining | PubMed |
| Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. | EBioMedicine | 2024 | 38614865 | PubTator, text mining | PubMed |
| Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis. | Endocr Relat Cancer | 2024 | 38614127 | PubTator, text mining | PubMed |
| Phosphorylation-regulated phase separation of syndecan-4 and syntenin promotes the biogenesis of exosomes. | Cell Prolif | 2024 | 38601993 | PubTator, text mining | PubMed |
| Effects of syndecan-4 silencing on the extracellular matrix remodeling in anoikis-resistant endothelial cells. | Cell Biol Int | 2024 | 38591778 | PubTator, text mining | PubMed |
| Urine proteome profile of firefighters with exposure to emergency fire-induced smoke: A pilot study to identify potential carcinogenic effects. | Sci Total Environ | 2024 | 38583625 | PubTator, text mining | PubMed |
| Basal endothelial glycocalyx's response to shear stress: a review of structure, function, and clinical implications. | Front Cell Dev Biol | 2024 | 38562144 | PubTator, text mining | PubMed |
| Retracted: LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis. | Biomed Res Int | 2024 | 38549976 | PubTator, text mining | PubMed |
| Sport medicine among the past three decades in China. | Chin Med J (Engl) | 2024 | 38533586 | PubTator, text mining | PubMed |
| Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes. | Diabetes | 2024 | 38530908 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. | Clin Transl Med | 2024 | 38426403 | PubTator, text mining | PubMed |
| Low dose cadmium inhibits syndecan-4 expression in glycocalyx of glomerular endothelial cells. | J Appl Toxicol | 2024 | 38396353 | PubTator, text mining | PubMed |
| Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes. | Cardiovasc Diabetol | 2024 | 38302978 | PubTator, text mining | PubMed |
| Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38289368 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of epithelial, immune, and stromal signatures and interactions in human ovarian cancer. | Commun Biol | 2024 | 38278958 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6385/papers?page=10